Table 1.

Follow-up participants confirmed positive for SARS-CoV-2 antibodies

	All (n = 76)	Positive for antibodies against N-protein after 16 weeks of follow-up (n = 46)	Negative for antibodies against N-protein after 16 weeks of follow-up (n = 30)	p value
Median age (in years)	36.5 (IQR 49.5–26.5)	40.0 (IQR 29.0–52.0)	27.5 (IQR 25.0–44.0)	0.017*
Age by category (in years)				0.072
18–29	31 (40.79%)	14 (44.33%)	17 (56.67%)
30–49	26 (34.21%)	18 (63.33%)	8 (26.67%)
50 and above	19 (25%)	14 (83.33%)	5 (16.67%)
Gender				0.664
Male	51 (67.11%)	30 (58.82%)	21 (41.18%)
Female	25 (32.89%)	16 (64%)	9 (36%)
Infection history				0.122
Symptomatic	60 (78.95%)	39 (65%)	21 (35%)
Asymptomatic	16 (21.05%)	7 (43.75%)	9 (56.25%)

*t test significant at p < 0.05 at 95% confidence interval